Figure 6 | Cell Death & Disease

Figure 6

From: Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells

Figure 6

LBL21 inhibited tumor growth on A549 xenograft study. Immune-deficient BALB/c nude mice were utilized to establish A549 xenograft. Both PEITC and LBL21 were administered three times per week intraperitoneally at 25 mg/kg dosage. (a and b) The tumor volume and mice weight were determined twice a week. (candd) Tumor weight was measured after the mice were killed. Bars means±S.D. *P<0.05, ***P<0.001, n=6. (e) A proposed mechanism model for our molecule LBL21

Back to article page